TS
Taysha Gene
TSHA·NASDAQDallas TXFounded 2019120 employees
Small CapbiotechPublicRare DiseaseNeurology
Platform: AAV CNS
Market Cap
$0.6B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (TSHA)
Loading TSHA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| TSH-7567 | TSH-7567 | Phase 1/2 | 2 | WRN | BCCMCL | ||
| Pemicagene | TSH-3035 | Phase 2 | 1 | GIP-R | HNSCC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)